CVD weekly pick
Management of Acute Coronary Syndrome.
JAMA. 2026 May 26;335(20):1808-1809.
0
Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2026 May 26;153(21):e1359.
0
Beyond weight loss: multisystem benefits of obesity medications.
The lancet. Diabetes & endocrinology. 2026 May 28;:.
0
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic Syndrome.
Kidney international. 2026 May 25;:.
0
Convergent Hybrid Ablation Versus Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure: HALT AF Study Protocol and Rationale for a Multicenter Randomized Controlled Trial.
Journal of the American Heart Association. 2026 May 29;:e047774.
0
[Not Available].
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2026 May 24;198(20):E784-E801.
0
State-of-the-art management of ischemic cardiomyopathy: integrating diagnostic pathways, revascularization strategies, and guideline-directed therapy.
Heart failure reviews. 2026 May 29;31(1):.
0
Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease.
American heart journal. 2026 May 26;:107493.
0
Consensus statement on mass spectrometry-based proteomic analysis of cardiac tissue.
Nature cardiovascular research. 2026 May 25;:.
0
Comparative Analysis of Randomized versus Real World Populations in Heart Failure: DIAMOND Trial versus CARE-HK Registry.
ESC heart failure. 2026 May 29;:.
0
Late-presenting ST-segment elevation myocardial infarction: is it just a matter of time? From temporal cutoffs to biological staging.
Trends in cardiovascular medicine. 2026 May 23;:.
0
Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF.
Circulation. Heart failure. 2026 May 28;:e013877.
0
Joint non-linear dose-response associations of device-measured physical activity and cardiorespiratory fitness with cardiovascular disease: a cohort and Mendelian randomisation study.
British journal of sports medicine. 2026 May 28;:.
0
Palliative care in stroke: Guidelines of the Spanish Society of Neurology's Stroke Study Group.
Neurologia. 2026 May 25;:502035.
0
Clinical Benefits of Medical Therapy in Adults With Congenital Heart Disease and Systemic Left Ventricular Presenting With Heart Failure With Reduced Ejection Fraction.
Journal of the American Heart Association. 2026 May 25;:e048260.
0
Combined Prognostic Value of Follow-Up Ejection Fraction and Natriuretic Peptide Measurements in Heart Failure With Reduced Ejection Fraction Following Initiation of Pharmacotherapy.
Journal of the American Heart Association. 2026 May 25;:e047015.
0
Chagas cardiomyopathy.
Heart (British Cardiac Society). 2026 May 25;:.
0
Improving Heart Failure Discharge Care Through a Resident-Led Quality Improvement Initiative.
JACC. Case reports. 2026 May 27;31(21):107940.
0
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry.
European heart journal. Quality of care & clinical outcomes. 2026 May 26;:.
0
Heart failure and COPD - guideline adherence, diagnostic characterisation and treatment quality.
European journal of internal medicine. 2026 May 25;:106965.
0